C6H6N4O
Neat
150.14
100047-45-8; 4-Amino-1H-pyrrolo[2, 3-d]pyrimidin-2(3H)-one; 4-Amino-1H-pyrrolo[2, 3-d]pyrimidin-2(7H)-one; 4-Amino-7H-pyrrolo[2, 3-d] pyrimidin-2-ol; 4-amino-3, 7-dihydropyrrolo[2, 3-d]pyrimidin-2-one; 4-Amino-1, 3-dihydro-2H-pyrrolo[2, 3-d]pyrimidin-2-one; Tofacitinib Impurity 180; 4-amino-1, 3-dihydropyrrolo[2, 3-d]pyrimidin-2-one; SCHEMBL19221872; DTXSID50663644; DB-349047; CS-0067327; F12220; 2H-Pyrrolo[2, 3-d]pyrimidin-2-one, 4-amino-1 and 7-dihydro- (9CI)
4-amino-3, 7-dihydropyrrolo[2 and 3-d]pyrimidin-2-one
InChI=1S/C6H6N4O/c7-4-3-1-2-8-5(3)10-6(11)9-4/h1-2H,(H4,7,8,9,10,11)